Optim Partners with 21st Century Oncology as the Preferred Vendor for Head and Neck Cancer Endoscopy
The ENTity™ XL Nasopharyngoscope has been selected by the leading health care provider as the preferred choice in technology utilized to diagnose and manage patients with head and neck cancers. STURBRIDGE, Mass., Sept. 7, 2018 -- (Healthcare Sales & Mar... Devices, Oncology Optim LLC, ENTityXL, Nasopharyngoscope, FreedomView, OptiLux (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 7, 2018 Category: Pharmaceuticals Source Type: news

Facebook, NYU feel need for MRI speed with AI
Can less really be more in MRI? Facebook and New York University (NYU) intend...Read more on AuntMinnie.comRelated Reading: Cinematic rendering bolsters AI for depth estimation on endoscopy AI algorithm can triage head CT exams for urgent review New opportunities emerge for AI in medical imaging AI algorithm generates 'artificial' medical images Deep learning performs superresolution MSK MRI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 24, 2018 Category: Radiology Source Type: news

Cinematic rendering bolsters AI for depth estimation on endoscopy
The photorealistic quality of cinematically rendered CT scans may reduce the...Read more on AuntMinnie.comRelated Reading: Physicians prefer cinematic rendering for ankle injuries Cinematic rendering sheds light on abdominal pathology Cinematic rendering aids diagnosis in aortic complication Video from RSNA 2017: Cinematic rendering -- Just pretty pictures or paradigm shift? AJR papers shine spotlight on cinematic rendering (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 21, 2018 Category: Radiology Source Type: news

MIT researchers developing implantable sensors
ReMix, a new technology in the works at MIT's Computer Science and Artificial Intelligence Laboratory, seeks to make progress toward a new paradigm of treatment – one that's less reliant on endoscopy and surgery, but instead relies on sensors and what scientists call an " in-body GPS " to help make diagnoses and guide drug administration. The goal, researchers said, is a new approach to patient care that's less expensive, invasive and time-consuming than has been previously been possible. (Source: mobihealthnews)
Source: mobihealthnews - August 20, 2018 Category: Information Technology Source Type: news

Fujifilm Sonosite taps Ueda as chair, CEO | Personnel Moves – August 9, 2018
Fujifilm‘s (TSE:4901) SonoSite subsidiary said earlier this week it appointed Fujifilm vet and current Fujifilm Medical Systems USA and Fujifilm New Development USA prez Takaaki Ueda as its new chair and CEO. Previously, Ueda has also served as Fujifilm global endoscopy systems division GM, the company said. Ueda will replace the departing Masayuki Higuchi who is returning to Tokyo to take the role of Fujifilm global finance & accounting deputy GM. Alongside the appointment, the company said it also promoted Rich Fabian to the position of prez and COO. Fabian had previously held various executive positions for 15...
Source: Mass Device - August 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Biolase Carmat Inc. Entellus Medical Inc. fujifilm Haemonetics johnsonandjohnson neurologics orthoconsulting personnel-moves PositiveID Corp. SonoSite Tactile Systems Technology Source Type: news

Pentax Bets on PlasmaBiotics in the Fight Against Scope-Related Infections
Pentax Medical, a division of the Hoya Group, acquired a controlling interest in PlasmaBiotics this week, an investment that is expected to strengthen Pentax's hygiene portfolio and help it reduce cross-contamination risks associated with endoscopy devices. Paris, France-based PlasmaBiotics makes devices designed for drying and storing endoscopes. Endoscope hygiene has been a hot-button topic in the gastroenterology sector and FDA has been cracking down on Pentax and other scope makers to make sure these manufacturers are doing sufficient post-market surveillance to assess contamination risks associated with th...
Source: MDDI - August 3, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Sterilization Source Type: news

7 medtech stories we missed this week: August 3, 2018
[Image from unsplash.com]From Esaote launching its new ultrasound device to Nipro’s Infraredx launching in Japan, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Esaote launches new ultrasound devices Esaote announced in an Aug. 2 press release that it has launched its new MyLab X7, MyLab X6 and MyLab X5 ultrasound systems. The MyLab X7 offers faster and more reliable ultrasounds with intuitive usability and ergonomics. MyLab X5 has zero-click automatic that speeds up assessments and enhances image quality. 2. Bonesupport inks deal with MTF Biologics Bonesuppor...
Source: Mass Device - August 3, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Catheters Diagnostics Food & Drug Administration (FDA) Hospital Care Imaging Regulatory/Compliance Software / IT Ultrasound Bonesupport Esaote InfraReDx Inc. ivwatch MedTech Mindshare Medical Modulated Imaging MTF Bi Source Type: news

Allurion Puts Consumers First with Weight Loss Balloon Treatment
Allurion Technologies is hoping to be able to get FDA approval to launch its obesity treatment balloon in 2020. The Natick, MA-based company said it was making progress toward its goal of getting Elipse on the U.S market by completing enrollment in the ENLIGHTEN clinical trial. The company exceeded its 400-patient target for the clinical study. “The reason we exceeded our target was because of the unprecedented demand that we experienced for the trial,” Shantanu Gaur, co-founder and CEO of Allurion, told MD+DI. “It was really astonishing to see the traffic numbers at our study website. All over the c...
Source: MDDI - July 24, 2018 Category: Medical Devices Authors: Omar Ford Tags: Implants Business Source Type: news

Analysts Expect Merit Medical & #039;s Hot Streak to Last
Terumo's loss appears to be Merit Medical's gain. Product shortages at the former benefitted Merit during the last two weeks of the second quarter by boosting sales across several product lines, including sheath introducers, guidewires, microcatheters, compression devices, and catheters.  Merit reported revenue of $224.8 million in the second quarter, which represents a 9.8% organic growth over the same period last year and beat analyst consensus of $214.7 million. To put it in terms of the company's expectations, CEO Fred Lampropoulos told investors during Tuesday's earnings call th...
Source: MDDI - July 24, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Boston Sci Just Won ’t Stop Buying Companies
There really doesn’t seem to be in sight to Boston Scientific’s recent buying spree. This time the Marlborough, Mass.-based company is picking up Claret Medical for about $220 million in upfront cash and a potential reimbursement-based milestone payment of up to $50 million. The deal is set to close sometime in the third quarter of 2018. Santa Rosa, CA-based Claret has developed and received clearance for the Sentinel Cerebral Embolic Protection System. The device is used to protect the brain during certain interventional procedures, predominately in patients undergoing transcatheter aortic valve replacement(TA...
Source: MDDI - July 20, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news

Key Surgical acquires Encompas Unlimited
Key Surgical recently announced that it has acquired Encompas Unlimited to expand its endoscopy product offerings. The financial details of the deal were not disclosed. This is the second acquisition that Key Surgical has completed after merging with Interlock Medizintechnik last year. Emcompas specializes in manufacturing, assembling and distribution a variety of endoscopy accessories and supplies. Get the full story on our sister site, Medical Design & Outsourcing. The post Key Surgical acquires Encompas Unlimited appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 13, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Blog encompasunlimited keysurgical Source Type: news

NHS posters remind surgeons to check they have the right patient
This comes after the  Oxford University John Radcliffe and Churchill hospitals had four mishaps in May and June. One incident saw surgeons inserting an endoscopy into the wrong patient. (Source: the Mail online | Health)
Source: the Mail online | Health - July 13, 2018 Category: Consumer Health News Source Type: news

Two NHS hospitals have put up posters reminding   surgeons to check they have the right patient
This comes after the  Oxford University John Radcliffe and Churchill hospitals had four mishaps in May and June. One incident saw surgeons inserting an endoscopy into the wrong patient. (Source: the Mail online | Health)
Source: the Mail online | Health - July 13, 2018 Category: Consumer Health News Source Type: news

Breathing Easier with Single-Use Bronchoscopes
This study was specifically done for bronchoscopes because that data was lacking,” says Lars Marcher, CEO and President Ambu A/S, in an interview with MD+DI. Contamination of reusable endoscopes has been known for some time now. “Endoscope Reprocessing Failures Continue to Expose Patients to Infection Risk” was number two on ECRI Institute’s list of Top 10 health technology hazards for 2018. And it has been on the organization’s top 10 list for the past eight years. Shifting to single-use instruments will likely be cost effective as well. According to a 2017 study, “Early Assessment...
Source: MDDI - July 12, 2018 Category: Medical Devices Authors: Susan Shepard Tags: Sterilization Source Type: news

Boston Scientific Continues to Be Relentless with M & amp;A
Boston Scientific is set to acquire Cryterion Medical, a company developing single-shot cryoablation platform for the treatment of atrial fibrillation (AF), for about $202 million in up-front cash. The price is for the 65% remaining stake in the Carlsbad, CA-based company, not already owned by Boston Scientific. The Cryterion Medical cryoablation platform uses cryothermal energy to interrupt the irregular electrical signals that can cause AF. Developed with a next-generation balloon catheter, advanced mapping catheter, steerable sheath and enhanced console, the system is designed to streamline overall procedural workflow, ...
Source: MDDI - July 5, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

A Resident ’s Right to Appeal a Facility-Initiated Discharge
On May 12, 2016, Mrs. D was admitted to an acute care facility after she was found collapsed in her home, unresponsive, covered with melenic stool, and with dried blood around her mouth. She could not provide a history, and her daughter (her caregiver) was unavailable. She was noted to have possible upper gastrointestinal bleeding, rhabdomyolysis (from a fall), and a urinary tract infection (UTI). She was hydrated aggressively, and her rhabdomyolysis and kidney injury resolved. Her upper endoscopy examination showed severe esophagitis and Barrett ’s esophagus. (Source: Caring for the Ages)
Source: Caring for the Ages - July 1, 2018 Category: Health Management Authors: William C. Wilson Tags: lEGAL iSSUEs Source Type: news

Dr. Gawande tapped to lead Amazon-JPM-Berkshire health play | Personnel Moves – June 21, 2018
The joint healthcare venture between Amazon (NSDQ:AMZN), Berkshire Hathaway and J.P. Morgan Chase said this week it named Brigham and Women’s Hospital surgeon, New Yorker magazine staff writer and bestselling author Dr. Atul Gawande as its CEO, effective July 9. The joint venture said that the newly formed company will be headquartered in Boston, and will operate as an independent entity free from profit-making incentives and constraints. Dr. Gawande also serves as a professor of Harvard Medical School and the Harvard T.H. Chan School of Public Health, and is the founding executive director of health system...
Source: Mass Device - June 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News AirXpanders Amazon Avantis Medical Systems Inc. Berkshire Hathaway Boston Scientific CHF Solutions Inc. Corindus Vascular Robotics Haemonetics Intuitive Surgical IsoRay JP Morgan Chase medicen Medtronic Source Type: news

OmniVision Sees Its Future in Medtech Clearly
Tazeeb Gunja holds up a case containing a dot the size of a period at OmniVision’s booth during MD&M East. This “dot” is a highly functional imaging technology created by OmniVision to be used in medical devices. “We plan to make some even smaller,” Gunja, who serves as principal market and development manager at OmniVision. The Santa Clara, CA-based company had a full display at MD&M East, showcasing its technology as it seeks to increase its market share in the medical device industry. The company, which was founded in 1995, revealed two new partnerships that could help give it a str...
Source: MDDI - June 14, 2018 Category: Medical Devices Authors: Omar Ford Tags: Imaging Electronics Source Type: news

Can You Smell a Bidding War Brewing Over Boston Scientific?
Monday's headlines that Stryker may be making a play for Boston Scientific prompted industry analysts to play the "what if" game, dissecting potential benefits of such a marriage, how a deal of that size might impact the broader medical device industry, and the potential of other bidders to emerge. Just to be clear though, we still do not know at this point if Stryker really has approached Boston Scientific about a potential takeover, or if Boston Scientific is even receptive to the idea. Both companies declined to comment on the speculation Monday, citing their respective company policies. Canaccord Genuity's Ja...
Source: MDDI - June 13, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Analysts: Stryker, Boston Scientific tie-up could create “ higher growth Medtronic ”
Analysts are eagerly digging into the news that Stryker (NYSE:SYK) put in a takeover bid with Boston Scientific (NYSE:BSX), though many were surprised by the news and are unsure of the obvious strategic value of the acquisition. News of the deal, which both companies have officially responded to with statemens of “no comment,” emerged yesterday at the Wall Street Journal. The merger could create a “higher growth Medtronic,” according to Evercore’s Vijay Kumar, adding approximately 2% to Stryker’s expected 2019 earnings per share and up to 6% by next year, SeekingAlpha repo...
Source: Mass Device - June 12, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Wall Street Beat Boston Scientific johnsonandjohnson Medtronic Stryker Source Type: news

Push Endoscopy
Title: Push EndoscopyCategory: Procedures and TestsCreated: 3/21/2008 12:00:00 AMLast Editorial Review: 6/11/2018 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - June 11, 2018 Category: Nutrition Source Type: news

7 medtech stories we missed this week: June 8, 2018
[Image from unsplash.com]From Royal Philips receiving FDA clearance to NeuroPace launching its epilepsy treatment device, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. FDA clears Philips’s Ingenia Elition 3.0T MR scanner Royal Philips announced in a June 5 press release that it has received FDA 510(k) clearance for its Ingenia Elition 3.0T MR solution and its two clinical applications Philips Compressed Sense and 3D APT. The products help clinicians perform exams up to 50% faster while increasing diagnostic confidence and improving patient experience. 2. Pent...
Source: Mass Device - June 8, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Diagnostics Endoscopic / Arthroscopic Food & Drug Administration (FDA) Hospital Care Imaging Implants Neurological Neuromodulation/Neurostimulation Patient Monitoring Regulatory/Compliance branchpointtechnologies Cook Medica Source Type: news

Digestive Disease Week, June 2-5
Digestive Disease Week 2018 The Digestive Disease Week annual meeting sponsored by the American Association for the Study of Liver Diseases, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy, and Society for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 7, 2018 Category: Pharmaceuticals Source Type: news

Colonoscopies, Endoscopies Carry Greater Infection Risk Than Thought: Study
Title: Colonoscopies, Endoscopies Carry Greater Infection Risk Than Thought: StudyCategory: Health NewsCreated: 6/6/2018 12:00:00 AMLast Editorial Review: 6/7/2018 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - June 7, 2018 Category: Nutrition Source Type: news

Colonoscopies, Endoscopies Carry Greater Infection Risk Than Thought: Study
WEDNESDAY, June 6, 2018 -- Getting a colonoscopy or an endoscopy may be riskier than you thought. Researchers report that the rate of infections following these procedures at outpatient ambulatory surgery centers could be 100 times higher than... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 6, 2018 Category: General Medicine Source Type: news

Korea ’ s IntroMedic wins FDA nod for MiroCam capsule endoscope, inks U.S. distro deal
Korea-based medtech company IntroMedic inked a deal with Stratis Medical to distribute its MicroCam video capsule endoscopy system in the U.S. The device is designed to visualize and monitor the small bowel mucosa. The MicroCam is the first capsule endoscopy system with E-Field Propagation or Human Body Communication, according to Stratis Medical – the proprietary tech uses the human body as a communication medium to provide high-resolution images for consistent and accurate monitoring of the small bowel. The latest MicroCam system includes software that receives, records and processes images faster and more efficien...
Source: Mass Device - June 1, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Food & Drug Administration (FDA) Imaging IntroMedic stratismedical Source Type: news

Digital health news briefs for 5/30/16
Practice, practice, practice.  Touch Surgery, a mobile surgical training platform, is collaborating with the American Society for Gastrointestinal Endoscopy to convert some of the society’s procedural videos into interactive mini-simulations at the Digestive Disease Week.  ASGE members will get the chance to try out the mobi le platform during the conference. The technology is a blend of digital and hands-on experiences and will let users try out several endoscopic procedures.  (Source: mobihealthnews)
Source: mobihealthnews - May 30, 2018 Category: Information Technology Source Type: news

Postcolonoscopy/Endoscopy Infection Rates Higher Than Thought Postcolonoscopy/Endoscopy Infection Rates Higher Than Thought
' The observed postendoscopic infection rates at some [ambulatory surgical centers] are over 100 times higher than their expected rates,'authors of a new study report.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 22, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Olympus inks distro deal for MI Tech ’ s Hanarostent
Olympus (TYO:7733) said yesterday it inked an exclusive deal to distribute M.I. Tech’s Hanarostent self-expanding metal stents. The deal includes both the FDA 510(k) cleared Hanarostent biliary and Hanarostent esophagus stents, Tokyo-based Olympus said, and marks the first of multiple self-expanding metal stents the company will include in its EndoTherapy portfolio. “We are confident in the hundreds of stents and other products in our portfolio that are already providing quality of life benefits to patients all over the world. Olympus is an ideal partner for us because of its trusted brand in the U.S. medi...
Source: Mass Device - May 22, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Stents mitech Olympus Source Type: news

Breath test can save money and catch cancer early
This test is a cheaper and less invasive alternative to an upper endoscopy. (Source: ABC News: Health)
Source: ABC News: Health - May 20, 2018 Category: Consumer Health News Tags: Health Source Type: news

Auris Health, Ethicon ’ s NeuWave ink robot-assisted bronchoscope ablation dev deal
Auris Health, previously known as Auris Surgical Robotics, said today it inked a cooperative development and commercialization deal with Johnson & Johnson (NYSE:JNJ) division Ethicon’s NeuWave Medical subsidiary looking to develop systems for the robotically-assisted bronchoscopic ablation of lung lesions. Through the agreement, both companies will help develop an integrated system for robotic control, navigation and application of bronchoscope-delivered microwave ablation. The bronchoscope in development will be equipped with a small camera and accessory channel to allow tools to enter the lungs through the...
Source: Mass Device - May 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Endoscopic / Arthroscopic Respiratory Robotics aurishealth Ethicon johnsonandjohnson NeuWave Medical Inc. Source Type: news

Is Meta-Analysis a Sign of Something Big on the Horizon for GID?
All signs are pointing to something big on the horizon for GI Dynamics and its embattled obesity and type 2 diabetes treatment technology. The most recent guidepost from the Lexington, MA-based company came Thursday, when it announced results were being published from a meta-analysis of the EndoBarrier. Results show the device was able to impact weight loss and insulin resistance improvement. The research is titled “Effects of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Type 2 Diabetic Patients with Obesity: A Meta-analysis with Secondary Analysis on Weight Loss and Hormonal Changes,” an...
Source: MDDI - May 10, 2018 Category: Medical Devices Authors: Omar Ford Tags: Implants Source Type: news

Single-Use Spray Takes Aim at GI Bleeds
Cook Medical has been focused on finding an easier way to treat patients suffering from gastrointestinal bleeds. For nearly 10 years the Bloomington IN-based company has been developing the Hemospray, a powder like device that has just received a nod from FDA. Barry Slowey, VP of Cook Medical’s Endoscopy specialty, said the company got the idea for Hemospray from an application used by the U.S. military in Afghanistan and Iraq to treat wounds on the battlefield. “If you look at the how bleeds are treated in the gastrointestinal tract, you see  the treatments are either mechanical, like an endoscopic clip&n...
Source: MDDI - May 8, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Hoya gets in on $15m round for 3NT Medical
3NT Medical said today that it drummed up “a major portion” of its maiden $15 million funding round from Japan’s Hoya Corp. (TYO:7741) Rosh Ha’Ayin, Israel-based 3NT is developing the Sinusway drivable endoscope for ear, nose and throat procedures. Proceeds from the round are slated for commercializing Sinusway in the U.S. and Europe and the completion of the company’s line of single-use endoscopes. Hoya, in its first venture investment in an Israeli firm, joins prior backers LongTec China Ventures and a consortium of angel investors, medical device industry veterans and ENT pra...
Source: Mass Device - May 8, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Otolaryngology Ear, Nose & Throat Wall Street Beat 3NT Medical Hoya Corp. Source Type: news

Cook Medical wins FDA de novo nod for Hemospray
Cook Medical said yesterday it won FDA de novo clearance for its Hemospray endoscopic hemostat designed for treating bleeding in the gastrointestinal tract. The Hemospray product won indications from the FDA for treating non-variceal GI bleeds, the Bloomington, Ind.-based company said. Hemospray is a single-use device designed to deliver an aerosolized spray of a mineral blend to a bleeding site during endoscopic procedures, and can cover large areas including ulcers and tumors, according to an FDA release. “We are extremely pleased to receive this approval to market from FDA. We have worked diligently to bring ...
Source: Mass Device - May 8, 2018 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Cook Medical Source Type: news

Olympus inks co-development deal with Ai4gi for AI-supported colonoscopy solution
Olympus (TYO:7733) said today it inked a co-development deal with artificial intelligence joint venture Ai4gi which will give Olympus exclusive rights to offer Ai4gi’s AI solution designed for clinical decision support during colonoscopy screening and surveillance procedures. Ai4gi is a joint venture between Imagia and Satis Operations, Tokyo-based Olympus said. The company added that the co-development agreement is intended to improve clinical outcomes during colonoscopy procedures, reduce costs and improve quality of life for patients. “Ai4gi’s solutions to early colon cancer recognition are going ...
Source: Mass Device - May 7, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Software / IT ai4gi Olympus Source Type: news

Health Tip: Prepare for a Colonoscopy
-- Many people who have had a colonoscopy say the prep is worse than the actual procedure. But it's a necessary evil. Improper preparation, and you might as well skip the test altogether. The American Society for Gastrointestinal Endoscopy advises... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 4, 2018 Category: General Medicine Source Type: news

Medineering touts first uses of Robotic Endoscopy system
German robotic surgical start-up Medineering said today its Medineering Robotic Endoscopy system was used in its first clinical procedures after having won CE Mark approval in the European Union last year. The company said that the robotic endoscopic system has been used in several clinical settings in university hospitals across Germany and Italy. The Robotic Endoscopy system is designed to support surgeons during minimally invasive ear, nose and throat surgery by moving and holding the endoscope. “The robotic solution is a great benefit for doing complex surgery in anatomical regions, where a clear and st...
Source: Mass Device - April 26, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Otolaryngology Ear, Nose & Throat Robotics Surgical Medineering Source Type: news

Olympus inks endoscope image sharing deal with InterSystems
Olympus (TYO:7733) said yesterday it inked a deal with InterSystems to enhance Olympus’ Knowledge Exchange System with InterSystems HealthShare, which allows for the sharing of images taken during endoscopy procedures. Olympus said its KE system is a software platform for centralized reprocessing record and image management that connects to its Olympus devices. The company added the system eliminates the need to transfer images to external devices to share with patients and other providers, and that with the addition of HealthShare it will now be able share endoscopic images and to directly connect to electronic...
Source: Mass Device - April 20, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Endoscopic / Arthroscopic Imaging Software / IT intersystems Olympus Source Type: news

FDA warns against endoscope connectors
The FDA yesterday warned healthcare providers against using endoscope connectors in more than one patient without reprocessing, saying it hasn’t seen any acceptable tests demonstrating their safety. The federal safety watchdog said the connectors, which are used in more than one patient for gastrointestinal endoscopies over the course of 24 hours, connect the endoscope to a water supply. The agency recommended that providers use connectors that prevent patient fluid back-flow into the ‘scope, either as a one-time use or reprocessed after every patient. Erbe USA is the only company marketing a 24-hour multi-pati...
Source: Mass Device - April 19, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Food & Drug Administration (FDA) Erbe USA Source Type: news

Cleaned endoscopes often contaminated
Many patients may be undergoing endoscopy with contaminated instruments, a pair of new studies suggest. (Source: Reuters: Health)
Source: Reuters: Health - April 18, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Cantel Medical wins FDA nod for Advantage Plus endoscope reprocessor
Cantel Medical (NYSE:CMD) said today it won FDA 510(k) clearance for its Advantage Plus pass-thru automated endoscope reprocessor, making it the first AER available in the US, the company claims. The newly cleared device is designed for the high-level disinfection of commonly used endoscopes, including duodenoscopes, the Little Falls, N.J.-based company said. “We strive to deliver real life infection prevention solutions to address the complexities our customers face in setting up successful endoscopy departments. We believe the Advantage Plus pass-thru AER’s availability will transform our custo...
Source: Mass Device - April 18, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Cantel Medical Corp. Source Type: news

Boston Sci Continues M & amp;A Hot Streak with nVision Buy
Boston Scientific isn’t slowing down with its M&A activity. This time the Marlborough, MA-based company is acquiring nVision Medical, a private company focused on women's health. The transaction consists of an upfront cash payment of $150 million, and up to an additional $125 million in potential clinical and commercial milestones over four years.  nVision’s device collects cells from the fallopian tubes, offering a potential platform for earlier diagnosis of ovarian cancer. “nVision Medical developed the first and only device cleared by the FDA to collect cells from the fallopian tubes,” K...
Source: MDDI - April 16, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

New recommendations for endoscopic eradication therapy in Barrett's esophagus
(American Society for Gastrointestinal Endoscopy) A new guideline by the ASGE Standards of Practice Committee offers evidence-based recommendations and clinical guidelines addressing key issues related to Endoscopic Eradication Therapy (EET) in the management of Barrett's esophagus (BE)-related lesions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 6, 2018 Category: International Medicine & Public Health Source Type: news

Applied Medical touts surgical GI wound protector study data
Applied Medical this week released results from a meta-analysis study of wound protectors used during lower gastro intestinal procedures, touting their ability to reduce surgical site infections. Results from the study were published this month in the journal Surgical Endoscopy, the Rancho Santa Margarita, Calif.-based company said. Data from the analysis, which examined 12 randomized controlled trials with 3,029 participants, indicated that use of wound protectors like the company’s Alexis system significantly reduced rates of SSI patients undergoing lower GI surgery. Furthermore, SSI rates were reduced by 63% when ...
Source: Mass Device - March 30, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Surgical Applied Medical Resources Corp. Source Type: news

OmniGuide ’ s Domain Surgical launches ferromagnetic vessel-sealing shears
OmniGuide said yesterday its subsidiary Domain Surgical launched its FMsealer laparoscopic shears designed for surgical vessel sealing. The Lexington, Mass.-based company touted the newly released FMsealer as the only vessel sealing instrument based on ferromagnetic surgical energy, which it claims provides quick transection with minimal thermal impact on surrounding tissue. The device is cleared for sealing vessles up to 7mm in diameter, including lymphatics in open and laparoscopic procedures, OmniGuide said. “The FMsealer Laparoscopic Shears offers intuitive plug-and-play capabilities with our award-winning F...
Source: Mass Device - March 30, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Surgical Vascular Domain Surgical OmniGuide Source Type: news

CDx & #039;s WATS3D Highly Effective in Real World Setting
CDx Diagnostics said results from a recent multicenter prospective trial show the use of its WATS3D test increases the detection of both Barrett’s esophagus and esophageal dysplasia by more than 80%. The results were published in the latest issue of United European Gastroenterology Journal and featured in the American Society for Gastrointestinal Endoscopy (ASGE’s) Scope Tech Talk Video Series. The trial was conducted at 25 community-based gastrointestinal (GI) centers across the U.S. In the study, 4,203 patients were tested for esophageal disease. The findings show that with the inclusion of WATS3D overal...
Source: MDDI - March 26, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Design News Source Type: news

UPDATE: Moll ’ s Auris wins FDA nod for Monarch robotic endoscopy platform
Updated to include commentary from Auris chief strategy officer Josh DeFonzo. Auris Health, previously known as Auris Surgical Robotics and formed by Intuitive Surgical (NSDQ:ISRG) founder Dr. Frederic Moll, said today it won FDA clearance for its Monarch robotic endoscopy platform. The Redwood City, Calif.-based company said it’s Monarch robotic platform’s initial aim will be on treating lung cancer, with the FDA clearance indicating the device for use in diagnostic and therapeutic bronchoscopic procedures. Auris touted that the system enables more accurate diagnosis and treatment of small and hard-to-rea...
Source: Mass Device - March 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Respiratory Robotics aurishealth Source Type: news

Moll ’ s Auris wins FDA nod for Monarch robotic endoscopy platform
Auris Health, previously known as Auris Surgical Robotics and formed by Intuitive Surgical (NSDQ:ISRG) founder Dr. Frederic Moll, said today it won FDA clearance for its Monarch robotic endoscopy platform. The Redwood City, Calif.-based company said it’s Monarch robotic platform’s initial aim will be on treating lung cancer, with the FDA clearance indicating the device for use in diagnostic and therapeutic bronchoscopic procedures. Auris touted that the system enables more accurate diagnosis and treatment of small and hard-to-reach nodules in the periphery of the lung. “Technology has advanced signif...
Source: Mass Device - March 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Respiratory Robotics aurishealth Source Type: news